The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage

The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer. The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined. NLR, PLR, MPV values were found to be higher in patie...

Full description

Saved in:
Bibliographic Details
Published in:Cancer investigation 2021-08, Vol.39 (6-7), p.514-520
Main Authors: Goksel, Sibel, Ozcelik, Neslihan, Telatar, Gokhan, Ardic, Cuneyt
Format: Article
Language:English
Subjects:
Aged
Biomarkers, Tumor - immunology
Case-Control Studies
Diagnostic value
Early Detection of Cancer
Female
Humans
lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - immunology
Lung Neoplasms - pathology
Lymphocyte Count
Male
mean platelet volume
Middle Aged
Neoplasm Staging
neutrophil-to-lymphocyte ratio
Neutrophils - metabolism
Platelet Count
platelet-to-lymphocyte ratio
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer. The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined. NLR, PLR, MPV values were found to be higher in patients with lung cancer (all p 
ISSN:0735-7907
1532-4192
DOI:10.1080/07357907.2021.1938110